Chemotherapy for small-bowel Adenocarcinoma at a single institution View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-01-08

AUTHORS

Mitsukuni Suenaga, Nobuyuki Mizunuma, Keisho Chin, Satoshi Matsusaka, Eiji Shinozaki, Masatoshi Oya, Masashi Ueno, Toshiharu Yamaguchi, Tetsuichiro Muto, Fumio Konishi, Kiyohiko Hatake

ABSTRACT

PurposeSmall-bowel adenocarcinoma (SBA) is rare. No standard chemotherapy for this type of cancer has yet been established. At Cancer Institute Hospital (CIH), the chemotherapy regimen used for colorectal cancer is initially used for patients with SBA, followed by that used for gastric cancer.MethodsPatients with advanced or recurrent SBA who had been treated with chemotherapy in CIH were retrospectively analyzed. The first-line treatments were fluoropyrimidines used alone or in combination with other drugs, such as 5-fluorouracil plus leucovorin (FL), UFT-E, or TS-1. The second-line treatment was irinotecan (CPT-11) monotherapy.ResultsFluoropyrimidine-based regimens, mainly FL, were used for 10 patients. Seven patients received the second-line CPT-11 regimen. Disease control was seen in five patients (50%) with the first-line chemotherapy and in three (43%) with the second-line. The median overall survival time was 12 months (range 3–39). The treatments were generally tolerated. Gastrointestinal symptoms were the most common adverse effects.ConclusionsFluoropyrimidines as the first-line and CPT-11 as the second-line chemotherapy yielded low response, although the adverse effects were mild. The FOLFOX and FOLFIRI regimens such as those used for metastatic colorectal cancer are potential alternative strategies. Extensive trials are needed to develop standard chemotherapy with new drugs. More... »

PAGES

27-31

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00595-008-3843-2

DOI

http://dx.doi.org/10.1007/s00595-008-3843-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018852954

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19132464


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestinal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestine, Small", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Irinotecan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leucovorin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitamin B Complex", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suenaga", 
        "givenName": "Mitsukuni", 
        "id": "sg:person.01024665203.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024665203.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizunuma", 
        "givenName": "Nobuyuki", 
        "id": "sg:person.01357134113.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357134113.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chin", 
        "givenName": "Keisho", 
        "id": "sg:person.01042133603.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042133603.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsusaka", 
        "givenName": "Satoshi", 
        "id": "sg:person.01125517543.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125517543.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shinozaki", 
        "givenName": "Eiji", 
        "id": "sg:person.01145664051.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145664051.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oya", 
        "givenName": "Masatoshi", 
        "id": "sg:person.0600237645.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600237645.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueno", 
        "givenName": "Masashi", 
        "id": "sg:person.01332557730.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332557730.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamaguchi", 
        "givenName": "Toshiharu", 
        "id": "sg:person.01225320503.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225320503.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muto", 
        "givenName": "Tetsuichiro", 
        "id": "sg:person.01353122256.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353122256.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Omiya Medical Center, Jichi Medical University, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415020.2", 
          "name": [
            "Department of Surgery, Omiya Medical Center, Jichi Medical University, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Konishi", 
        "givenName": "Fumio", 
        "id": "sg:person.01272216415.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272216415.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.486756.e", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hatake", 
        "givenName": "Kiyohiko", 
        "id": "sg:person.01252161657.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252161657.78"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02303567", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033828140", 
          "https://doi.org/10.1007/bf02303567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01366941", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020675959", 
          "https://doi.org/10.1007/bf01366941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.523", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015493174", 
          "https://doi.org/10.1038/bjc.1998.523"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-01-08", 
    "datePublishedReg": "2009-01-08", 
    "description": "PurposeSmall-bowel adenocarcinoma (SBA) is rare. No standard chemotherapy for this type of cancer has yet been established. At Cancer Institute Hospital (CIH), the chemotherapy regimen used for colorectal cancer is initially used for patients with SBA, followed by that used for gastric cancer.MethodsPatients with advanced or recurrent SBA who had been treated with chemotherapy in CIH were retrospectively analyzed. The first-line treatments were fluoropyrimidines used alone or in combination with other drugs, such as 5-fluorouracil plus leucovorin (FL), UFT-E, or TS-1. The second-line treatment was irinotecan (CPT-11) monotherapy.ResultsFluoropyrimidine-based regimens, mainly FL, were used for 10 patients. Seven patients received the second-line CPT-11 regimen. Disease control was seen in five patients (50%) with the first-line chemotherapy and in three (43%) with the second-line. The median overall survival time was 12 months (range 3\u201339). The treatments were generally tolerated. Gastrointestinal symptoms were the most common adverse effects.ConclusionsFluoropyrimidines as the first-line and CPT-11 as the second-line chemotherapy yielded low response, although the adverse effects were mild. The FOLFOX and FOLFIRI regimens such as those used for metastatic colorectal cancer are potential alternative strategies. Extensive trials are needed to develop standard chemotherapy with new drugs.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00595-008-3843-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1102161", 
        "issn": [
          "0941-1291", 
          "1436-2813"
        ], 
        "name": "Surgery Today", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "keywords": [
      "Cancer Institute Hospital", 
      "standard chemotherapy", 
      "colorectal cancer", 
      "median overall survival time", 
      "adverse effects", 
      "CPT-11 regimen", 
      "second-line chemotherapy", 
      "second-line treatment", 
      "first-line chemotherapy", 
      "metastatic colorectal cancer", 
      "small bowel adenocarcinoma", 
      "first-line treatment", 
      "common adverse effects", 
      "overall survival time", 
      "types of cancer", 
      "chemotherapy regimen", 
      "gastrointestinal symptoms", 
      "Institute Hospital", 
      "irinotecan monotherapy", 
      "single institution", 
      "gastric cancer", 
      "CPT-11", 
      "survival time", 
      "chemotherapy", 
      "patients", 
      "Disease Control", 
      "potential alternative strategy", 
      "cancer", 
      "new drugs", 
      "low response", 
      "regimen", 
      "adenocarcinoma", 
      "treatment", 
      "drugs", 
      "FOLFOX", 
      "FOLFIRI", 
      "MethodsPatients", 
      "monotherapy", 
      "leucovorin", 
      "fluoropyrimidines", 
      "regimens", 
      "UFT", 
      "hospital", 
      "symptoms", 
      "trials", 
      "months", 
      "extensive trials", 
      "alternative strategies", 
      "effect", 
      "SBA", 
      "response", 
      "control", 
      "TS-1", 
      "FL", 
      "combination", 
      "institutions", 
      "strategies", 
      "types", 
      "time"
    ], 
    "name": "Chemotherapy for small-bowel Adenocarcinoma at a single institution", 
    "pagination": "27-31", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018852954"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00595-008-3843-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19132464"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00595-008-3843-2", 
      "https://app.dimensions.ai/details/publication/pub.1018852954"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_488.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00595-008-3843-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00595-008-3843-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00595-008-3843-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00595-008-3843-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00595-008-3843-2'


 

This table displays all metadata directly associated to this object as RDF triples.

292 TRIPLES      22 PREDICATES      109 URIs      98 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00595-008-3843-2 schema:about N08acf054a838456e9f3edaac7a11d0a8
2 N0f9ed3b89615438ea203d629823af5d3
3 N1330bd8bbf41474eb48bdff336ef8e97
4 N140d57216046446fbe6a2fab61746556
5 N22ef6cdd68324eafa12357d54a139f05
6 N29dbf21454c146638ea4917a10b55ca7
7 N3285ba2fa16a4c90b19ee740b3af9854
8 N335aac325426492f9aadb8ca0c96ca34
9 N4cfebf2c6cf74f59a0c1b700e5288d31
10 N5c908ba65472427099fb6a82d6fea3b4
11 N5e0ec9f65550456e803482fc5a4c6b37
12 N5eb0dbb645ae4427b2e92638cd77061c
13 N65aaddb8922647518f68aebf523b2f02
14 N6ae487556d164f298cd8df3687c537b4
15 N6c8a5e8a9c814c7983403510312e40cf
16 N72a9124dd84f4d3cacdf580d618c8720
17 N91495e6a63034133bf066bb537b9c2ab
18 Na4312b9352d54b4c9ed4ad297d9fc459
19 Nb6e7328cc3b845b59dd9548be0a6c76c
20 Nd11b90909fe3489583d9e63169862fa2
21 Ne8173a1737ea4c77856b0a0977e35bbd
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N460e09fbc08348c089ad73388a7c1056
25 schema:citation sg:pub.10.1007/bf01366941
26 sg:pub.10.1007/bf02303567
27 sg:pub.10.1038/bjc.1998.523
28 schema:datePublished 2009-01-08
29 schema:datePublishedReg 2009-01-08
30 schema:description PurposeSmall-bowel adenocarcinoma (SBA) is rare. No standard chemotherapy for this type of cancer has yet been established. At Cancer Institute Hospital (CIH), the chemotherapy regimen used for colorectal cancer is initially used for patients with SBA, followed by that used for gastric cancer.MethodsPatients with advanced or recurrent SBA who had been treated with chemotherapy in CIH were retrospectively analyzed. The first-line treatments were fluoropyrimidines used alone or in combination with other drugs, such as 5-fluorouracil plus leucovorin (FL), UFT-E, or TS-1. The second-line treatment was irinotecan (CPT-11) monotherapy.ResultsFluoropyrimidine-based regimens, mainly FL, were used for 10 patients. Seven patients received the second-line CPT-11 regimen. Disease control was seen in five patients (50%) with the first-line chemotherapy and in three (43%) with the second-line. The median overall survival time was 12 months (range 3–39). The treatments were generally tolerated. Gastrointestinal symptoms were the most common adverse effects.ConclusionsFluoropyrimidines as the first-line and CPT-11 as the second-line chemotherapy yielded low response, although the adverse effects were mild. The FOLFOX and FOLFIRI regimens such as those used for metastatic colorectal cancer are potential alternative strategies. Extensive trials are needed to develop standard chemotherapy with new drugs.
31 schema:genre article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N4bb09798cd9a4617915a5d933a717372
35 N5e2f6a18a1264fd68eaf5c33ff2f1880
36 sg:journal.1102161
37 schema:keywords CPT-11
38 CPT-11 regimen
39 Cancer Institute Hospital
40 Disease Control
41 FL
42 FOLFIRI
43 FOLFOX
44 Institute Hospital
45 MethodsPatients
46 SBA
47 TS-1
48 UFT
49 adenocarcinoma
50 adverse effects
51 alternative strategies
52 cancer
53 chemotherapy
54 chemotherapy regimen
55 colorectal cancer
56 combination
57 common adverse effects
58 control
59 drugs
60 effect
61 extensive trials
62 first-line chemotherapy
63 first-line treatment
64 fluoropyrimidines
65 gastric cancer
66 gastrointestinal symptoms
67 hospital
68 institutions
69 irinotecan monotherapy
70 leucovorin
71 low response
72 median overall survival time
73 metastatic colorectal cancer
74 monotherapy
75 months
76 new drugs
77 overall survival time
78 patients
79 potential alternative strategy
80 regimen
81 regimens
82 response
83 second-line chemotherapy
84 second-line treatment
85 single institution
86 small bowel adenocarcinoma
87 standard chemotherapy
88 strategies
89 survival time
90 symptoms
91 time
92 treatment
93 trials
94 types
95 types of cancer
96 schema:name Chemotherapy for small-bowel Adenocarcinoma at a single institution
97 schema:pagination 27-31
98 schema:productId Nc1a33d01e0534561963bf60397e7f5eb
99 Ne4050f7319ad4b8fb9c22e6bae518ca2
100 Nf7820408190f44469c9603e195c5fb06
101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018852954
102 https://doi.org/10.1007/s00595-008-3843-2
103 schema:sdDatePublished 2022-05-20T07:25
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher N05797aa9f1754141a38d8fb6096325f2
106 schema:url https://doi.org/10.1007/s00595-008-3843-2
107 sgo:license sg:explorer/license/
108 sgo:sdDataset articles
109 rdf:type schema:ScholarlyArticle
110 N030f03d8b39046d6a7124177fe18b75b rdf:first sg:person.01252161657.78
111 rdf:rest rdf:nil
112 N05797aa9f1754141a38d8fb6096325f2 schema:name Springer Nature - SN SciGraph project
113 rdf:type schema:Organization
114 N08acf054a838456e9f3edaac7a11d0a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Intestine, Small
116 rdf:type schema:DefinedTerm
117 N0f9ed3b89615438ea203d629823af5d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Irinotecan
119 rdf:type schema:DefinedTerm
120 N1330bd8bbf41474eb48bdff336ef8e97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Antineoplastic Combined Chemotherapy Protocols
122 rdf:type schema:DefinedTerm
123 N140d57216046446fbe6a2fab61746556 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Follow-Up Studies
125 rdf:type schema:DefinedTerm
126 N17dde14fe5a54fdbbd54adf723041920 rdf:first sg:person.01225320503.15
127 rdf:rest N66dbe0f0ccd44a58b22d6242533e683e
128 N2170d1c92dde45128d3513d3e543325f rdf:first sg:person.01042133603.45
129 rdf:rest N282e6269dccb484f8ad545e708b11d5e
130 N22ef6cdd68324eafa12357d54a139f05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Aged
132 rdf:type schema:DefinedTerm
133 N282e6269dccb484f8ad545e708b11d5e rdf:first sg:person.01125517543.23
134 rdf:rest Nc237bb3c10b34d7eb8f85a5373eafede
135 N29dbf21454c146638ea4917a10b55ca7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Camptothecin
137 rdf:type schema:DefinedTerm
138 N3285ba2fa16a4c90b19ee740b3af9854 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Middle Aged
140 rdf:type schema:DefinedTerm
141 N332ff0e4c38d4d31b549fdb86c959ce9 rdf:first sg:person.01357134113.91
142 rdf:rest N2170d1c92dde45128d3513d3e543325f
143 N335aac325426492f9aadb8ca0c96ca34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Intestinal Neoplasms
145 rdf:type schema:DefinedTerm
146 N460e09fbc08348c089ad73388a7c1056 rdf:first sg:person.01024665203.77
147 rdf:rest N332ff0e4c38d4d31b549fdb86c959ce9
148 N4bb09798cd9a4617915a5d933a717372 schema:volumeNumber 39
149 rdf:type schema:PublicationVolume
150 N4cfebf2c6cf74f59a0c1b700e5288d31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Survival Rate
152 rdf:type schema:DefinedTerm
153 N5c908ba65472427099fb6a82d6fea3b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Humans
155 rdf:type schema:DefinedTerm
156 N5e0ec9f65550456e803482fc5a4c6b37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Disease Progression
158 rdf:type schema:DefinedTerm
159 N5e2f6a18a1264fd68eaf5c33ff2f1880 schema:issueNumber 1
160 rdf:type schema:PublicationIssue
161 N5eb0dbb645ae4427b2e92638cd77061c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Neoplasm Metastasis
163 rdf:type schema:DefinedTerm
164 N65aaddb8922647518f68aebf523b2f02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Female
166 rdf:type schema:DefinedTerm
167 N66dbe0f0ccd44a58b22d6242533e683e rdf:first sg:person.01353122256.33
168 rdf:rest Nf41ec0d735c449dcb4e200cf3cdbaa58
169 N6ae487556d164f298cd8df3687c537b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Adenocarcinoma
171 rdf:type schema:DefinedTerm
172 N6c8a5e8a9c814c7983403510312e40cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Adult
174 rdf:type schema:DefinedTerm
175 N72a9124dd84f4d3cacdf580d618c8720 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Retrospective Studies
177 rdf:type schema:DefinedTerm
178 N7dc9b17be1214275b12c967fb34938a7 rdf:first sg:person.0600237645.04
179 rdf:rest N9e541e9378314c3d9d46f1c7a93ce1f9
180 N91495e6a63034133bf066bb537b9c2ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Tomography, X-Ray Computed
182 rdf:type schema:DefinedTerm
183 N9e541e9378314c3d9d46f1c7a93ce1f9 rdf:first sg:person.01332557730.68
184 rdf:rest N17dde14fe5a54fdbbd54adf723041920
185 Na4312b9352d54b4c9ed4ad297d9fc459 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Vitamin B Complex
187 rdf:type schema:DefinedTerm
188 Nb6e7328cc3b845b59dd9548be0a6c76c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Fluorouracil
190 rdf:type schema:DefinedTerm
191 Nc1a33d01e0534561963bf60397e7f5eb schema:name doi
192 schema:value 10.1007/s00595-008-3843-2
193 rdf:type schema:PropertyValue
194 Nc237bb3c10b34d7eb8f85a5373eafede rdf:first sg:person.01145664051.07
195 rdf:rest N7dc9b17be1214275b12c967fb34938a7
196 Nd11b90909fe3489583d9e63169862fa2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Male
198 rdf:type schema:DefinedTerm
199 Ne4050f7319ad4b8fb9c22e6bae518ca2 schema:name pubmed_id
200 schema:value 19132464
201 rdf:type schema:PropertyValue
202 Ne8173a1737ea4c77856b0a0977e35bbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Leucovorin
204 rdf:type schema:DefinedTerm
205 Nf41ec0d735c449dcb4e200cf3cdbaa58 rdf:first sg:person.01272216415.22
206 rdf:rest N030f03d8b39046d6a7124177fe18b75b
207 Nf7820408190f44469c9603e195c5fb06 schema:name dimensions_id
208 schema:value pub.1018852954
209 rdf:type schema:PropertyValue
210 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
211 schema:name Medical and Health Sciences
212 rdf:type schema:DefinedTerm
213 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
214 schema:name Oncology and Carcinogenesis
215 rdf:type schema:DefinedTerm
216 sg:journal.1102161 schema:issn 0941-1291
217 1436-2813
218 schema:name Surgery Today
219 schema:publisher Springer Nature
220 rdf:type schema:Periodical
221 sg:person.01024665203.77 schema:affiliation grid-institutes:grid.486756.e
222 schema:familyName Suenaga
223 schema:givenName Mitsukuni
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024665203.77
225 rdf:type schema:Person
226 sg:person.01042133603.45 schema:affiliation grid-institutes:grid.486756.e
227 schema:familyName Chin
228 schema:givenName Keisho
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042133603.45
230 rdf:type schema:Person
231 sg:person.01125517543.23 schema:affiliation grid-institutes:grid.486756.e
232 schema:familyName Matsusaka
233 schema:givenName Satoshi
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125517543.23
235 rdf:type schema:Person
236 sg:person.01145664051.07 schema:affiliation grid-institutes:grid.486756.e
237 schema:familyName Shinozaki
238 schema:givenName Eiji
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145664051.07
240 rdf:type schema:Person
241 sg:person.01225320503.15 schema:affiliation grid-institutes:grid.486756.e
242 schema:familyName Yamaguchi
243 schema:givenName Toshiharu
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225320503.15
245 rdf:type schema:Person
246 sg:person.01252161657.78 schema:affiliation grid-institutes:grid.486756.e
247 schema:familyName Hatake
248 schema:givenName Kiyohiko
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252161657.78
250 rdf:type schema:Person
251 sg:person.01272216415.22 schema:affiliation grid-institutes:grid.415020.2
252 schema:familyName Konishi
253 schema:givenName Fumio
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272216415.22
255 rdf:type schema:Person
256 sg:person.01332557730.68 schema:affiliation grid-institutes:grid.486756.e
257 schema:familyName Ueno
258 schema:givenName Masashi
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332557730.68
260 rdf:type schema:Person
261 sg:person.01353122256.33 schema:affiliation grid-institutes:grid.486756.e
262 schema:familyName Muto
263 schema:givenName Tetsuichiro
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353122256.33
265 rdf:type schema:Person
266 sg:person.01357134113.91 schema:affiliation grid-institutes:grid.486756.e
267 schema:familyName Mizunuma
268 schema:givenName Nobuyuki
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357134113.91
270 rdf:type schema:Person
271 sg:person.0600237645.04 schema:affiliation grid-institutes:grid.486756.e
272 schema:familyName Oya
273 schema:givenName Masatoshi
274 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600237645.04
275 rdf:type schema:Person
276 sg:pub.10.1007/bf01366941 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020675959
277 https://doi.org/10.1007/bf01366941
278 rdf:type schema:CreativeWork
279 sg:pub.10.1007/bf02303567 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033828140
280 https://doi.org/10.1007/bf02303567
281 rdf:type schema:CreativeWork
282 sg:pub.10.1038/bjc.1998.523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015493174
283 https://doi.org/10.1038/bjc.1998.523
284 rdf:type schema:CreativeWork
285 grid-institutes:grid.415020.2 schema:alternateName Department of Surgery, Omiya Medical Center, Jichi Medical University, Saitama, Japan
286 schema:name Department of Surgery, Omiya Medical Center, Jichi Medical University, Saitama, Japan
287 rdf:type schema:Organization
288 grid-institutes:grid.486756.e schema:alternateName Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
289 Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
290 schema:name Department of Medical Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
291 Division of Gastroenterological Surgery, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
292 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...